NCT02387866View on ClinicalTrials.gov

PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 2, 2015

Primary Completion Date

May 21, 2015

Study Completion Date

July 27, 2015

Conditions
Healthy
Interventions
DRUG

AG-221

Trial Locations (1)

91206

Parexel International, Glendale

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY